CLINICAL_TRIALS
trial_result
· 2016-10-26
Clinical Trial Update: Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma [Phase 1]
Summary
A Phase 1 trial evaluating hydroxychloroquine administered before surgery in patients with renal cell carcinoma was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Pittsburgh | Conditions: Renal Cell Carcinoma | Phase 1 | Status: TERMINATED